Does DAPAGLIFLOZIN Cause Neoplasm malignant? 119 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 119 reports of Neoplasm malignant have been filed in association with DAPAGLIFLOZIN (QTERN). This represents 0.6% of all adverse event reports for DAPAGLIFLOZIN.
119
Reports of Neoplasm malignant with DAPAGLIFLOZIN
0.6%
of all DAPAGLIFLOZIN reports
16
Deaths
19
Hospitalizations
How Dangerous Is Neoplasm malignant From DAPAGLIFLOZIN?
Of the 119 reports, 16 (13.4%) resulted in death, 19 (16.0%) required hospitalization, and 1 (0.8%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAPAGLIFLOZIN. However, 119 reports have been filed with the FAERS database.
What Other Side Effects Does DAPAGLIFLOZIN Cause?
Death (2,775)
Diabetic ketoacidosis (1,773)
Acute kidney injury (982)
Off label use (891)
Nausea (884)
Dehydration (860)
Vomiting (838)
Dizziness (817)
Ketoacidosis (803)
Fatigue (785)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which DAPAGLIFLOZIN Alternatives Have Lower Neoplasm malignant Risk?
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN
DAPAGLIFLOZIN vs DAPRODUSTAT
DAPAGLIFLOZIN vs DAPSONE
DAPAGLIFLOZIN vs DAPTOMYCIN